about
Graft-versus-host disease after simultaneous pancreas-kidney transplantation: a case report and review of the literatureDevelopment of an immunoassay for the kidney-specific protein myo-inositol oxygenase, a potential biomarker of acute kidney injuryDetection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.Detection of gene rearrangements in targeted clinical next-generation sequencing.Cell adhesion receptors in C. elegans.Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy.The C. elegans zonula occludens ortholog cooperates with the cadherin complex to recruit actin during morphogenesisPre-analytical variables in miRNA analysis.Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs.Design of a Genomics Curriculum: Competencies for Practicing Pathologists.T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides.ETRAP (efficient trapping and purification) of target protein polyclonal antibodies from GST-protein immune sera.Validation of lamellar body counts using three hematology analyzers.Circulating miR-122 as a potential biomarker of liver disease.Validation of a next-generation sequencing assay for clinical molecular oncology.Catecholamine interference in enzymatic creatinine assays.Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations.Infantile NTRK-associated Mesenchymal Tumors.Expression of the Na+/K+-transporting ATPase gamma subunit FXYD2 in renal tumors.Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy.Clinical utility of miRNAs in diagnosis and prognosis.Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer.Direct-to-consumer genetic testing: reliable or risky?Premenopausal amenorrhea: what's in a number?A 5-month-old boy with delay in growth and development and decreased muscle tone.Pan-Trk Immunohistochemistry Identifies NTRK rearrangements in Pediatric Mesenchymal Tumors.Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.Clinical next-generation sequencing in patients with non-small cell lung cancer.The Undergraduate Training in Genomics (UTRIG) Initiative: early & active training for physicians in the genomic medicine era.Microsatellite instability in prostate cancer by PCR or next-generation sequencing.Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewDesmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 MutationsTargeted Next-Generation Sequencing of Acute LeukemiaCommentaryDiagnostic Utility of Targeted Next-generation Sequencing in Problematic CasesDirect-to-Consumer Cardiac Screening Tests: User BewareGiant Pediatric Rhabdoid Meningioma Associated with a Germline BAP1 Pathogenic Variation: A Rare Clinical CasePreliminary support for a “dry swab, extraction free” protocol for SARS-CoV-2 testing via RT-qPCR
P50
Q27010161-6C4C33DA-D0D0-43AA-88CF-F886DFDCEEB0Q28307099-28F43308-B6B3-4ABF-8C34-7F5504AD8C57Q30577735-249688E5-CBB3-44DC-B522-A6351756D7E2Q33833183-D368FC55-CE5A-4835-8EC3-E0EC047F277BQ35748298-C46F9F55-1F60-45C7-BB04-7B4E5491ABFCQ36959754-1D02FCD6-BB6A-4F3B-9B24-5BB49DE4A6B7Q37019181-B9F58941-9A2B-4E87-8EEE-9B07823A436EQ38087166-F1B02197-2988-4F9C-8B92-120F02D8165DQ38175636-C88AFB6F-0979-45EA-A861-7EEE1EA75463Q39183943-017780DE-C7BC-42D0-AF5F-64B25AD8F7F9Q40782374-4C898377-7117-4414-BC5D-CDA7BB15EF03Q40864739-1168F672-E917-4865-9065-72901CB62446Q42835499-C3FE7F60-F12F-45A2-9321-D1B9BBBE6CC4Q42934779-78CBDC3C-BB2C-414C-BB15-2D0012B705D5Q45194892-1129127B-2C61-45EB-AC00-4B4966599219Q45823548-59D7DD4B-C7FC-4ABA-BFF8-A3534C182557Q45933687-D63AC930-B35D-49DC-B404-CA6AB32DFE76Q45978399-974B3B43-E3BB-4F14-A33E-B2A7E55EBEB0Q46044924-BE5AE49F-1932-4C9A-BE2E-8A1CC57B1A6DQ46606708-45A176B9-977C-426F-A771-20EE73247E4BQ47705996-91A22443-3108-4D8F-924C-C7818DD92A54Q48233246-FB449B2B-3816-4BEE-B75A-0E6760062984Q48254761-6F9F109C-6E0B-4CC5-8E7F-B6A66D837DEEQ50513237-91CC4099-6D57-4C1D-8174-B27FD6A4CEACQ50668262-AC590E83-E0AB-4D67-B1E1-ABB8FAC65F41Q50987027-80EBBAF6-EA5D-49D2-B3CB-64A0CF24C426Q52570214-537130BC-5CFF-4E23-ACAC-1E31B4D9BDC0Q52674273-AF224F3E-5194-418A-A12A-7F28716F0CBAQ54313342-3E43A453-50CB-4816-80B4-CEC1B4D9EFB8Q55224854-7891E255-9218-43FA-8135-982E44935349Q55264193-FAC74286-059D-42EC-A76D-7B2C5287B545Q57134395-85C45527-9D78-4728-B051-7381F8B79E69Q63213728-EDA4B086-6A71-432D-8F09-863A7161EF6CQ63213732-D6A93B40-7971-4AA4-977B-8E3961B146C3Q63213737-D9B4BB7A-1CCC-4934-83EB-740BA9951587Q63213738-1FF3EDF5-CC1A-419D-85D7-F1EBE37B62E6Q63213742-FE974547-98A9-43AE-810E-4D3DEB9B50B6Q64044555-A07BF724-0F5B-4126-B9E6-63CF2576776CQ95627378-BAF8D693-39C5-48FC-98FE-D7493871947E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christina M. Lockwood
@ast
Christina M. Lockwood
@en
Christina M. Lockwood
@es
Christina M. Lockwood
@nl
Christina M. Lockwood
@sl
type
label
Christina M. Lockwood
@ast
Christina M. Lockwood
@en
Christina M. Lockwood
@es
Christina M. Lockwood
@nl
Christina M. Lockwood
@sl
altLabel
Christina Tuskey
@en
Tina Lockwood
@en
prefLabel
Christina M. Lockwood
@ast
Christina M. Lockwood
@en
Christina M. Lockwood
@es
Christina M. Lockwood
@nl
Christina M. Lockwood
@sl
P106
P1153
26639606100
P21
P31
P496
0000-0001-9036-7604